BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29527380)

  • 1. Bartter Syndrome Type 1 Presenting as Nephrogenic Diabetes Insipidus.
    Vergine G; Fabbri E; Pedini A; Tedeschi S; Borsa N
    Case Rep Pediatr; 2018; 2018():9175271. PubMed ID: 29527380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic variability in Bartter syndrome type I.
    Bettinelli A; Ciarmatori S; Cesareo L; Tedeschi S; Ruffa G; Appiani AC; Rosini A; Grumieri G; Mercuri B; Sacco M; Leozappa G; Binda S; Cecconi M; Navone C; Curcio C; Syren ML; Casari G
    Pediatr Nephrol; 2000 Sep; 14(10-11):940-5. PubMed ID: 10975303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype correlations in normotensive patients with primary renal tubular hypokalemic metabolic alkalosis.
    Bettinelli A; Vezzoli G; Colussi G; Bianchetti MG; Sereni F; Casari G
    J Nephrol; 1998; 11(2):61-9. PubMed ID: 9589375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of Bartter syndrome type I with atypical presentations.
    Lee EH; Heo JS; Lee HK; Han KH; Kang HG; Ha IS; Choi Y; Cheong HI
    Korean J Pediatr; 2010 Aug; 53(8):809-13. PubMed ID: 21189980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel homozygous CLCNKB variant: An early presentation of classic Bartter syndrome in a neonate.
    Yaprak D; Kara H; Calisici E; Karagöl BS; Altan M
    Birth Defects Res; 2023 Oct; 115(17):1674-1679. PubMed ID: 37587715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited primary renal tubular hypokalemic alkalosis: a review of Gitelman and Bartter syndromes.
    Shaer AJ
    Am J Med Sci; 2001 Dec; 322(6):316-32. PubMed ID: 11780689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel SLC12A1 (NKCC2) mutations in two families with Bartter syndrome type 1.
    Adachi M; Asakura Y; Sato Y; Tajima T; Nakajima T; Yamamoto T; Fujieda K
    Endocr J; 2007 Dec; 54(6):1003-7. PubMed ID: 17998760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel SLC12A1 gene mutation associated with hyperparathyroidism, hypercalcemia, nephrogenic diabetes insipidus, and nephrocalcinosis in four patients.
    Wongsaengsak S; Vidmar AP; Addala A; Kamil ES; Sequeira P; Fass B; Pitukcheewanont P
    Bone; 2017 Apr; 97():121-125. PubMed ID: 28095294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene.
    Drosataki E; Maragkou S; Dermitzaki K; Stavrakaki I; Lygerou D; Latsoudis H; Pleros C; Petrakis I; Zaganas I; Stylianou K
    BMC Nephrol; 2022 May; 23(1):182. PubMed ID: 35549682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antenatal Bartter Syndrome Caused by a Novel Homozygous Mutation in
    Acar FA; Işik G; Mutlu M; Kader Ş; Aslan Y; Kalyoncu M
    Indian J Nephrol; 2019; 29(5):360-363. PubMed ID: 31571745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel SLC12A1 mutation in Bedouin kindred with antenatal Bartter syndrome type I.
    Halperin D; Dolgin V; Geylis M; Drabkin M; Yogev Y; Wormser O; Schreiber R; Shalev H; Landau D; Birk OS
    Ann Hum Genet; 2019 Sep; 83(5):361-366. PubMed ID: 30977917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal Bartter syndrome presenting as hyperparathyroidism with hypercalcemia and hypercalciuria: a case report and review.
    Gross I; Siedner-Weintraub Y; Simckes A; Gillis D
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):943-6. PubMed ID: 25741940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated nephrocalcinosis due to compound heterozygous mutations in renal outer medullary potassium channel.
    Khandelwal P; Sabanadesan J; Sinha A; Hari P; Bagga A
    CEN Case Rep; 2020 Aug; 9(3):232-236. PubMed ID: 32185747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bartter Syndrome Type 1 Due to Novel
    Kiuchi Z; Nozu K; Yan K; Jüppner H
    JCEM Case Rep; 2023 Mar; 1(2):luad019. PubMed ID: 37908481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eight novel KCNJ1 variants and parathyroid hormone overaction or resistance in 5 probands with Bartter syndrome type 2.
    Zuo J; Guo W; Wang S; Lang Y; Wang S; Shi X; Zhang R; Zhao X; Han Y; Shao L
    Clin Chim Acta; 2020 Dec; 511():248-254. PubMed ID: 33058840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel SLC12A1 mutations cause Bartter syndrome in two patients with different prognoses.
    Yi S; Li M; Yang Q; Zhang X; Chen F; Qin Z; Yi S; Huang L; Wei H; Zhang Q; Luo J
    Clin Chim Acta; 2022 Jun; 531():120-125. PubMed ID: 35358470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutation of
    Cho HW; Lee ST; Cho H; Cheong HI
    Korean J Pediatr; 2016 Nov; 59(Suppl 1):S103-S106. PubMed ID: 28018459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bartter and related syndromes: the puzzle is almost solved.
    Rodríguez-Soriano J
    Pediatr Nephrol; 1998 May; 12(4):315-27. PubMed ID: 9655365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes.
    Bettinelli A; Bianchetti MG; Girardin E; Caringella A; Cecconi M; Appiani AC; Pavanello L; Gastaldi R; Isimbaldi C; Lama G
    J Pediatr; 1992 Jan; 120(1):38-43. PubMed ID: 1731022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.